首页> 美国卫生研究院文献>Journal of the Boston Society of Medical Sciences >Modulation of Notch Signaling Elicits Signature Tumors and Inhibits Hras1-Induced Oncogenesis in the Mouse Mammary Epithelium
【2h】

Modulation of Notch Signaling Elicits Signature Tumors and Inhibits Hras1-Induced Oncogenesis in the Mouse Mammary Epithelium

机译:Notch信号调节引发特征性肿瘤并抑制小鼠乳腺上皮细胞中Hras1诱导的肿瘤发生。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Deregulation of Notch signaling, which normally affects a broad spectrum of cell fates, has been implicated in various neoplastic conditions. Here we describe a transgenic mouse model, which demonstrates that expression of a constitutively active form of the Notch1 receptor in the mammary epithelium induces the rapid development of pregnancy/lactation-dependent neoplasms that consistently exhibit a characteristic histopathological pattern. These signature tumors retain the ability to respond to apoptotic stimuli and regress on initiation of mammary gland involution, but eventually appear to progress in subsequent pregnancies to nonregressing malignant adenocarcinomas. Additionally, we present evidence indicating that cyclin D1 is an >in vivo target of Notch signals in the mammary glands and demonstrate that we can effectively inhibit Hras1-driven, cyclin D1-dependent mammary oncogenesis by transgenic expression of the Notch antagonist Deltex.
机译:通常影响多种细胞命运的Notch信号的失调涉及多种肿瘤病症。在这里,我们描述了一个转基因小鼠模型,该模型证明了Notch1受体在乳腺上皮细胞中的组成型活性形式的表达诱导了妊娠/泌乳依赖性肿瘤的快速发展,这些肿瘤始终表现出特征性的组织病理学模式。这些标志性肿瘤保留了对凋亡刺激的反应能力,并在启动乳腺退化后会消退,但最终似乎在随后的妊娠中进展为无消退的恶性腺癌。此外,我们提供的证据表明,细胞周期蛋白D1是乳腺Notch信号的“体内”靶标,并证明我们可以通过转基因表达Hras1驱动的,依赖细胞周期蛋白D1的乳腺肿瘤发生而有效抑制。缺口拮抗剂Deltex。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号